Back

Repeat ablation for persistent AF: additional continuous complex activity mapping vs sole Re-PVI - Results of the randomized AF CAM study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Ablation for atrial fibrillation: some clinical issues you want to know Catheter Ablation of Arrhythmias ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Stephan Willems

Asklepios St. Georg Clinic, Hamburg (Germany)

5 More presentations in this session

Presentation thumbnail
Pulsed-field ablation versus conventional thermal ablation for atrial fibrillation: a meta-analysis of randomised controlled trials
Professor R. Sakurai (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
De novo pulmonary vein isolation in women with paroxysmal atrial fibrillation: a comparison between pulsed field vs thermal ablation
Professor M. Casella (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of pulsed field ablation for the cavotricuspid isthmus using an over-the-wire circular multielectrode array catheter
Doctor O. Inaba (Saitama, JP)
Abstract Slides Video
Presentation thumbnail
Dual-energy lattice-tip ablation system for atrial fibrillation: acute results from the Affera Global Registry
Doctor S. Boveda (Toulouse, FR)
Abstract Slides Video
Presentation thumbnail
Predictors of hemodynamic and respiratory instability during pulmonary vein isolation: findings from a retrospective cohort
Doctor V. Buia (Fuerth, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Ablation for atrial fibrillation: some clinical issues you want to know

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Late-Breaking Clinical Trials: atrial fibrillation ablation and rhythm control
thumbnail
Congress Session
Late-Breaking Science: paroxysmal atrial fibrillation ablation
thumbnail
Congress Presentation
ABC-AF study - a randomised controlled study of personalised treatment to reduce stroke or death in atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources